Transphorm, Inc (TGAN) Reports In-Line Q3 EPS

Transphorm, Inc (OTC: TGAN) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Transphorm, Inc (TGAN) click here.

You May Also Be Interested In

• William Blair Downgrades On Holding AG (ONON) to Market Perform
• TON Strategy Company (TONX) Tops Q2 EPS by 264c
• Zura Bio (ZURA) Misses Q2 EPS by 2c